1-3 of 3
David Stojdl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4052: Direct selection of PD1+ CD39+ tumor infiltrating lymphocytes (TIL) from tumor dissociates enrich for functional tumor-reactive cells

Free
Christophe Pedros, Larissa Pikor, Anna Fritzsche, Zachary K. Jilesen, Bethany Macleod, Niloufar Khojandi, Bryant Thompson, Matthew Thayer, Nikolas Bryan, Emily Carron, Sowbarnika S Ratliff, April Fraley, Jake Nikota, Robert Fisher, Sebastien Delpeut, Anna Kluew, Madysson Scott, Christian Laing, Leo He, Antoine Bernard, Nathalie Brassard, Simon Turcotte, Timothy J Langer, David Stojdl, Stewart Abbot, Barbara Sennino
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4052.
https://doi.org/10.1158/1538-7445.AM2023-4052
Published: 04 April 2023
View articletitled, Abstract 4052: Direct selection of PD1+ CD39+ tumor infiltrating lymphocytes (TIL) from tumor dissociates enrich for functional tumor-reactive cells
Journal Articles

Abstract 1473: Dual oncolytic viral immunotherapy generates large polyfunctional tumour-specific CD8 + T cell responses that infiltrate immunosuppressive tumors

Free
David Stojdl
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1473.
https://doi.org/10.1158/1538-7445.AM2019-1473
Published: 01 July 2019
View articletitled, Abstract 1473: Dual oncolytic viral immunotherapy generates large polyfunctional tumour-specific CD8 + T cell responses that infiltrate immunosuppressive tumors
Journal Articles

Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency

Free
Alexander Muik, Lawton J. Stubbert, Roza Z. Jahedi, Yvonne Geiβ, Janine Kimpel, Catherine Dold, Reinhard Tober, Andreas Volk, Sabine Klein, Ursula Dietrich, Beta Yadollahi, Theresa Falls, Hrvoje Miletic, David Stojdl, John C. Bell, Dorothee von Laer
Journal: Cancer Research
Series: Author Choice
Cancer Res (2014) 74 (13): 3567–3578.
https://doi.org/10.1158/0008-5472.CAN-13-3306
Published: 30 June 2014
View articletitled, Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
Open the PDF for Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency in another window
Includes: Supplementary data